Abstract
A prominent role for complement has been identified in the linkage of innate and adaptive immunity. The liver is the main source of complement and hepatocytes are the primary sites for synthesis of complement components in vivo. We have discovered that hepatitis C virus (HCV) impairs C4 and C3 synthesis. Liver damage may diminish capacity of complement synthesis in patients. However, we observed that the changes in measured complement components in chronically HCV infected patients do not correlate with liver fibrosis or rheumatoid factor present in the blood, serum albumin, or alkaline phosphatase levels. Complement component C3 is of critical importance in B cell activation and T cell-dependent antibody responses. C3 activity is required for optimal expansion of CD8+T cells during a systemic viral infection. Deficiencies in complement may predispose patients to infections via ineffective opsonization, and defects in lytic activity via membrane attack complex. Interestingly, C9 is significantly reduced at the mRNA level in chronically HCV infected liver biopsy specimens, while many hepatocyte derived complement components (C6, C8, Factor B, MASP1, and MBL) and unrelated genes remain mostly unaffected. This implies an HCV specific effect, not a global effect from liver disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Negro F, Alberti A (2011) The global health burden of hepatitis C virus infection. Liver Int 31(Suppl 2):1–3
Gasque P (2004) Complement: a unique innate immune sensor for danger signals. Mol Immunol 41:1089–1098
Kim DD, Song WC (2006) Membrane complement regulatory proteins. Clin Immunol 118:127–136
Mollnes TE, Song WC, Lambris JD (2002) Complement in inflammatory tissue damage and disease. Trends Immunol 23:61–64
Blue CE, Spiller OB, Blackbourn DJ (2004) The relevance of complement to virus biology. Virology 319:176–184
Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058–1066
Pangburn MK, Ferreira VP, Cortes C (2008) Discrimination between host and pathogens by the complement system. Vaccine 26(Suppl 8):I15–I21
Hourcade D, Liszewski MK, Krych-Goldberg M, Atkinson JP (2000) Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology 49:103–116
Seya T, Atkinson JP (1989) Functional properties of membrane cofactor protein of complement. Biochem J 264:581–588
Williams P, Chaudhry Y, Goodfellow IG, Billington J, Powell R, Spiller OB et al (2003) Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A. J Biol Chem 278:10691–10696
Banerjee A, Mazumdar B, Meyer K, Di Bisceglie AM, Ray RB, Ray R (2011) Transcriptional repression of C4 complement by hepatitis C virus proteins. J Virol 85:4157–4166
Kim H, Meyer K, Di Bisceglie AM, Ray R (2013) Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function. J Virol 87:5858–5867
Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB et al (2013) Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles. J Virol 87:7902–7910
Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB et al (2012) Hepatitis C virus proteins inhibit C3 complement production. J Virol 86:2221–2228
Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R (2016) Distinct CD55 isoform synthesis and inhibition of complement-dependent cytolysis by hepatitis C virus. J Immunol 197:1127–1136
Pio R, Corrales L, Lambris JD (2014) The role of complement in tumor growth. Adv Exp Med Biol 772:229–262
Dumestre-Perard C, Ponard D, Drouet C, Leroy V, Zarski JP, Dutertre N et al (2002) Complement C4 monitoring in the follow-up of chronic hepatitis C treatment. Clin Exp Immunol 127:131–136
Ali OS, Abo-Shadi MA, LN H (2005) The biological significance of serum complements C3 and C4 in HCV-related chronic liver diseases and hepatocellular carcinoma. Egypt J Immunol 12:91–99
El-Fatah Fahmy Hanno A, Mohiedeen KM, Deghedy A, Sayed R (2014) Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment. Arab J Gastroenterol 15:58–62
Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785–797
Peitsch MC, Tschopp J (1991) Assembly of macromolecular pores by immune defense systems. Curr Opin Cell Biol 3:710–716
Amet T, Ghabril M, Chalasani N, Byrd D, Hu N, Grantham A et al (2012) CD59 incorporation protects hepatitis C virus against complement-mediated destruction. Hepatology 55:354–363
Roden MM, Lee KH, Panelli MC, Marincola FM (1999) A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J Immunol Methods 226:29–41
Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V (1987) Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 165:848–864
Osuka F, Endo Y, Higuchi M, Suzuki H, Shio Y, Fujiu K et al (2006) Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor. Genomics 88:316–322
Coyne KE, Hall SE, Thompson S, Arce MA, Kinoshita T, Fujita T et al (1992) Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 149:2906–2913
Miot S, Crespo S, Schifferli JA (2002) Distinct forms of DAF in urine and blood. J Immunol Methods 260:43–53
Caras IW, Weddell GN (1989) Signal peptide for protein secretion directing glycophospholipid membrane anchor attachment. Science 243:1196–1198
Kim H, Meyer K, Di Bisceglie AM, Ray R (2014) Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components. PLoS One 9:e101422
Okroj M, Holmquist E, King BC, Blom AM (2012) Functional analyses of complement convertases using C3 and C5-depleted sera. PLoS One 7:e47245
Acknowledgments
Our research was supported by research grants DK080812 from NIDDK, U54-AI057160 from the NIAID to the Midwest Regional center of Excellence (MRCE) for Biodefense and Emerging Infectious Diseases Research, and from the Presidential and Liver Center Research Funds of Saint Louis University.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kwon, YC., Ray, R. (2019). Complement Regulation and Immune Evasion by Hepatitis C Virus. In: Law, M. (eds) Hepatitis C Virus Protocols . Methods in Molecular Biology, vol 1911. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8976-8_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8976-8_23
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8975-1
Online ISBN: 978-1-4939-8976-8
eBook Packages: Springer Protocols